256 results match your criteria: "AP-HP-Universite Paris[Affiliation]"
RMD Open
January 2025
Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, Centre de Référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Ile-de-France, Centre et Martinique, Service de Médecine Interne 2, Institut E3M, Paris, France, paris, France.
BJOG
December 2024
Service de Médecine Interne, Centre de référence Des Maladies Auto-Immunes et Auto-Inflammatoires systémiques Rares d'Ile-de-France, de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Université Paris Cité, Paris, France.
Objective: To assess safety of fertility treatments in women with systemic lupus erythematosus (SLE).
Design: Data from the multicentre French observational GR2 (Groupe de Recherche sur la Grossesse et les Maladies Rares) study (2014-ongoing).
Setting: Seventy-six centres in France.
Blood Adv
November 2024
Hopital Saint Louis, Paris, France.
The aim of our study was to analyze the potential survival benefit associated with HSCT according to clinico-biological scores which incorporate molecular data (MIPSS70 and MIPSS70+V2) to facilitate decision-making in this context. One transplant (n=241) and one non-transplant cohorts (n=239) were used to test the hypothesis that PMF patients with higher risk molecular score benefit from HSCT. A weighted propensity score was applied to balance confounding factors with the transplanted cohort as reference.
View Article and Find Full Text PDFHum Vaccin Immunother
December 2024
Health Economics and Outcomes Research, Moderna France, Paris, France.
Fertil Steril
October 2024
Department of Reproductive Medicine and Fertility Preservation, AP-HP - Université Paris-Saclay- Antoine Beclère Hospital, Clamart, France; Physiologie et physiopathologie endocrinienne, Université Paris Saclay, Inserm, Le Kremlin-Bicêtre, France.
FEBS J
January 2025
Laboratoire Cellules Souches et Applications Thérapeutiques, UMR INSERM 1184, Commissariat à l'Energie Atomique et Aux Energies Alternatives, Fontenay-Aux-Roses, France.
Prognosis of acute myeloid leukemia (AML) remains poor especially in older patients who are ineligible for standard chemotherapy or have refractory disease. Here, we study the potential of Peroxisome Proliferator-Activated Receptor (PPAR)-γ agonist pioglitazone to improve the treatment of AML. We show that pioglitazone exerts an anti-proliferative and anti-clonogenic effect on AML cell lines KG-1a, MOLM-14 and OCI-AML3 and on primary cultures from AML patients.
View Article and Find Full Text PDFClin Kidney J
September 2024
Department of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Background: Creatinine-based equations are the most used to estimate glomerular filtration rate (eGFR). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), the re-expressed Lund-Malmö Revised (r-LMR) and the European Kidney Function Consortium (EKFC) equations are the most validated. The EKFC and r-LMR equations have been suggested to have better performances in young adults, but this is debated.
View Article and Find Full Text PDFNat Rev Dis Primers
September 2024
Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
BMC Med Educ
August 2024
Université Paris Cité, AP-HP, Hôpital Cochin, Service d'Accueil des Urgences, Paris, France.
Background: The value of simulation in emergency medicine is indisputable because it allows training and acquisition of many technical and non-technical skills (TS and NTS). In France, there are no curriculum regarding the use of simulation as a teaching tool during emergency medicine residency. The aim of this study was to design the content of a national simulation-based curriculum for emergency medicine residency programs.
View Article and Find Full Text PDFRheumatology (Oxford)
August 2024
Service de Médecine Interne, Centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares d'Ile-de-France, de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP) - Université Paris Cité. Paris, France.
J Antimicrob Chemother
September 2024
Immunologie des Maladies Virales, Auto-immunes, Hématologiques et Bactériennes, Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.
Background: One major barrier to HIV cure is the persistence of virus, possibly linked to an insufficient antiretroviral drug (ARV) distribution into tissues.
Objectives: To draw the whole-body distribution of three antiretroviral drugs-tenofovir disoproxil fumarate, emtricitabine and dolutegravir-in non-human primates (NHPs).
Methods: Eight uninfected NHPs received a single injection of a solution containing the three ARVs.
Front Immunol
July 2024
Paris-City University, Mére et Enfants en Milieu Tropical: pathogénes, systéme de santé et transition épidémiologique (MERIT), Institute of Research for Development (IRD), Paris, France.
Neurol Genet
August 2024
From the Medicine Genetics Group (M.C.-R., L.B.-P., M.C.-S., J.L.-C., E.F.T.), Vall d'Hebron Research Institute (VHIR); Department of Clinical and Molecular Genetics (M.C.-R., L.B.-P., M.C.-S., J.L.-C., E.F.T.), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Neuromuscular Unit (L.G., M.G.-G.D.B., R.G.-U., P.S.-V., S.D., S.Q.-R.), Pediatric Neurology and ICU Department, Raymond Poincaré Hospital (UVSQ), AP-HP Université Paris-Saclay, Garches; and Laboratoire END-ICAP - UMR 1179 (INSERM/UVSQ) (S.Q.-R.), Equipe 1 Biothérapies des maladies neuromusculaires, Montigny-Le-Bretonneux, France.
Liver Int
October 2024
Oncology Digestive Unit, INSERM U1312, University Hospital of Bordeaux, Bordeaux, France.
Thorax
August 2024
Paediatric Pulmonology Department and Reference Center for Rare Lung Diseases, RespiRare, Sorbonne University, AP-HP, Armand Trousseau Hospital, Paris, France
J Infect
August 2024
Vedanta Biosciences Inc., Cambridge, MA 02139, USA.
J Exp Med
August 2024
Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
Fertil Steril
September 2024
Department of Reproductive Medicine and Fertility Preservation, Antoine Beclère Hospital, AP-HP-Université Paris-Saclay, Clamart, France; Physiologie et Physiopathologie Endocrinienne, Inserm, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Objective: To study the fertility outcomes of women who tried to conceive after breast cancer (BC) treatment and fertility preservation.
Design: Retrospective observational, bicentric cohort study.
Setting: University hospital.
J Hosp Infect
June 2024
Service de Biologie Clinique, hôpital Foch, Suresnes, France.
Background: The duration of extensively drug-resistant bacteria (XDR) carriage depends on several factors for which the information can be difficult to recover.
Aim: To determine whether past screening and clinical results of patients can predict the results of subsequent screening.
Methods: In total, 256 patients were retrospectively included from 10 healthcare centres in France from January 2014 to January 2022.
Lancet
November 2023
Service de Réanimation Polyvalente, Antoine Béclère Hospital, AP-HP Université Paris-Saclay, Clamart 92140, France. Electronic address:
Ann Intensive Care
November 2023
Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Berlin, Germany.
Background: Early mobilisation (EM) is an intervention that may improve the outcome of critically ill patients. There is limited data on EM in COVID-19 patients and its use during the first pandemic wave.
Methods: This is a pre-planned subanalysis of the ESICM UNITE-COVID, an international multicenter observational study involving critically ill COVID-19 patients in the ICU between February 15th and May 15th, 2020.
Int J Mol Sci
October 2023
CHU de Poitiers, Service de Cancérologie Biologique, F86000 Poitiers, France.
Eur Radiol
May 2024
Service de Radiologie, AP-HP-Université Paris Saclay Hôpital Paul Brousse, 12-14 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.
Cytometry A
February 2024
Inflammation, Microbiome and Immunosurveillance, UMR-996, Université Paris-Saclay, Inserm, Orsay, France.
Flow cytometry is a relevant tool to meet the requirements of academic and industrial research projects aimed at estimating the features of a bacterial population (e.g., quantity, viability, activity).
View Article and Find Full Text PDF